January 4, 2018 / 11:19 AM / Updated 18 minutes ago BRIEF-NanoString And RikenGenesis Announce Partnership To Commercialize Ncounter-Based Diagnostic Assays In Japan Reuters Staff 
Jan 4 (Reuters) - Nanostring Technologies Inc: 
* NANOSTRING AND RIKENGENESIS ANNOUNCE PARTNERSHIP TO COMMERCIALIZE NCOUNTER-BASED DIAGNOSTIC ASSAYS IN JAPAN 
* NANOSTRING -‍ UNDER AGREEMENT, CO, RIKEN GENESIS TO COLLABORATE TO REGISTER, OBTAIN REIMBURSEMENT, COMMERCIALIZE COMPANION DIAGNOSTIC ASSAYS IN JAPAN​ Source text for Eikon: Further company coverage: